Related by context. All words. (Click for frequent words.) 70 Hepatitis B virus 70 HCV 69 hepatitis B virus 69 HBsAg 66 hepatitis B virus HBV 65 HBV infection 64 hepatitis C virus 64 hepatitis B 63 Hepatitis B 63 latent tuberculosis infection 63 Hepatitis B Virus 62 hepatitis B infection 62 chronic HBV 62 HCV infection 62 surface antigen HBsAg 62 CMV disease 61 Hepatitis B virus HBV 61 chronic HBV infection 61 CMV 61 NRTI resistance 60 CMV infection 60 chronic hepatitis B 60 HCV infected 60 hepatitis C virus HCV 60 Hepatitis C virus 60 LTBI 59 HPV 59 seronegative 59 VZV 59 latent TB infection 59 Chlamydia trachomatis 59 latent TB 58 antiviral therapy 58 chlamydial infection 58 chlamydial 58 chronic hepatitis B. 58 Respiratory Syncytial Virus RSV 58 chronic HCV 58 HIV 58 BRCA mutation 58 M#V mutation 58 H pylori 58 asymptomatic carriers 57 latent tuberculosis 57 HCV antibody 57 RhD negative 57 CD8 responses 57 H. pylori 57 HBV vaccine 57 virus HBV 57 CHIKV 57 HBeAg negative 57 H. pylori infection 57 hepatitis B. 57 chronic hepatitis 57 hepatitis B HBV 57 S. aureus 57 tuberculin skin testing 57 fluoroquinolone resistance 57 HCV infections 56 HIV HCV coinfected 56 HPV-#/# 56 RhD 56 HBeAg 56 K#R [002] 56 EGFR mutation 56 cytomegalovirus 56 Human Papillomavirus 56 Candida species 56 K#N 56 asymptomatic 56 S. suis 56 CCR5 antagonist 56 HBV genotype 56 seropositivity 55 Telbivudine 55 Neisseria gonorrhoeae 55 ApoE4 allele 55 herpes zoster shingles 55 BRAF mutation 55 replicon 55 coagulase negative staphylococci 55 breast carcinomas 55 ELISPOT 55 lamivudine 55 cervical intraepithelial neoplasia 55 serologic 55 seropositive 55 antibody titer 55 CCR5 tropic HIV 55 Hepatitis C Virus 55 BARACLUDE ® 55 NNRTI 55 S.aureus 55 HBeAg positive 55 C. trachomatis 55 NS4A 55 nucleotide analog 55 viral subtypes 55 N. gonorrhoeae 55 BCG refractory 55 pulmonary TB 55 chronic HCV infection 55 HCV antibodies 55 adefovir 55 Hep B 55 viraemia 55 HCV genotype 1 55 GBV C 55 HPV# 54 pneumococcal infection 54 e antigen HBeAg 54 herpesviruses 54 CIN2 + 54 IgM antibodies 54 BCG vaccinated 54 reinfection 54 postexposure prophylaxis 54 Staphylococcus aureus infections 54 Hepatitis C virus HCV 54 tuberculin skin test 54 HBV DNA 54 EBV infection 54 Mantoux test 54 T SPOT.TB 54 chronic Hepatitis B 54 NNRTI resistance 54 seroconversion 54 HCV genotypes 54 Salmonella typhi 54 lamivudine resistant 54 cervical lesions 54 pyrimethamine 54 HPV genotypes 54 germline mutations 54 epithelial tumors 54 viremia 54 humoral responses 54 antigen 54 4CMenB 54 adenoviral 54 hepatitis C HCV 54 pneumococcal 54 KRAS mutation 54 Epstein Barr virus EBV 54 nasopharyngeal carcinoma 54 CCR5 receptor antagonist 54 hemagglutination inhibition 54 HPV infection 54 MDR tuberculosis 54 avian influenza viruses 54 recurrent genital herpes 54 ROTARIX 54 autoantibodies 54 NNRTIs 54 Asymptomatic 54 virologic failure 54 HBV infected 54 hepatitis C genotype 54 posaconazole 53 pneumococci 53 Ixiaro 53 transfusion transmitted 53 gastric adenocarcinoma 53 HBV carriers 53 BVDV 53 UGT#A# 53 immunosuppressed patients 53 Elacytarabine 53 multidrug resistant 53 HIV RNA 53 immunocompetent 53 S. aureus infections 53 germline mutation 53 antibody responses 53 hepatitis C infection 53 telbivudine 53 decompensated liver disease 53 Raltegravir 53 K ras mutations 53 Human Papilloma Virus 53 HIV1 53 HER2/neu 53 hepatoma 53 antiviral efficacy 53 genital ulcer disease 53 HLA DQ2 53 IgM 53 B CLL 53 H#Y 53 recombinants 53 Recombinant interferon alpha 53 latently infected 53 latent infection 53 HCV genotype 53 anti HBs 53 IgG antibodies 53 tipranavir ritonavir 53 hepatocellular carcinoma 53 BRAF V#E mutation 53 Salmonella spp 53 PCV2 53 JAK2 V#F 53 avian influenza virus 53 HER2 overexpression 53 DAS# [001] 53 cell lymphomas 53 HIV uninfected 53 activating mutations 53 mutated KRAS gene 53 Enterobacteriaceae 53 rotaviruses 53 recurrent ovarian cancer 53 tumor necrosis 53 neutralizing antibodies 53 hep B 53 Hepatitis C HCV 53 hepatocellular carcinoma HCC 53 H. influenzae 53 prostate cancer CaP 53 multidrug resistant strains 53 Candida infection 53 sero positive 53 entecavir 53 viral antigen 53 co receptor tropism 53 CDAD 53 genotypic resistance 53 Treatment Naive HIV 53 Vidofludimus 53 monoclonal antibody MAb 53 conjugate vaccine 53 HBeAg seroconversion 53 Chronic Prostatitis 53 varicella zoster virus VZV 53 superinfection 53 H#Y mutation 53 HPAI H#N# 53 serogroup C 53 nucleoside analogue 53 Valortim R 53 ovarian carcinoma 53 influenzae 53 cytomegalovirus CMV 53 protease inhibitor PI 53 N. meningitidis 53 poliovirus vaccine 53 HPV subtypes 53 MYH9 gene 52 Epidermal Growth Factor Receptor 52 multidrug resistance 52 GIST tumors 52 HAV infection 52 meningococcus 52 raltegravir 52 BRCA2 mutations 52 HPV infections 52 serogroup B 52 CMV infections 52 CIN3 52 Gleevec resistant 52 combination antiretroviral therapy 52 cervical HPV 52 HIV infection 52 Hepatitis C 52 ritonavir boosted 52 coinfected 52 colorectal cancer CRC 52 chemoprophylaxis 52 simplex virus 52 dengue viruses 52 quinolone resistant 52 Herpes Simplex Virus 52 grade cervical intraepithelial 52 Hib meningitis 52 HLA B 52 nelfinavir 52 precursor lesions 52 MenB 52 T#I mutation 52 APTIVUS 52 Human Papillomavirus HPV 52 BRCA mutations 52 coinfection 52 MRSA colonization 52 monoclonal 52 K ras gene 52 leukemia ALL 52 chlamydial infections 52 MenACWY 52 Sebivo 52 Shigella 52 elvucitabine 52 cytomegalovirus infection 52 Vacc 4x 52 virus HCV 52 genotype 52 BRAF mutations 52 FLT3 52 peginterferon 52 enterotoxigenic E. coli 52 BARACLUDE R 52 serotype #A 52 M. leprae 52 colorectal carcinoma 52 P. falciparum parasites 52 viremic 52 viral strains 52 enterococcal 52 Adhibit 52 Rh negative 52 MAb 52 TYZEKA 52 NPM1 mutation 52 nucleoside naive 52 human immunodeficiency virus 52 EpCAM 52 hepatitis C 52 serologic testing 52 seroconverted 52 methicillin sensitive 52 Clevudine 52 polio measles mumps rubella 52 HIV coinfected 52 Cytomegalovirus CMV 52 CMV retinitis 52 immunopathology 52 FTC TDF 52 BARACLUDE 52 S. pneumoniae 52 virulence genes 52 Rifampin 52 Etravirine 52 MRSA strains 52 Epstein Barr Virus EBV 52 Trichomonas vaginalis 52 abnormal cytology 52 influenza subtypes 52 Gag polymorphisms 52 vivax malaria 52 genital herpes infections 52 herpes infection 52 serogroup 52 CD# [002] 52 EGFR inhibitors 52 immunological responses 52 BRCA1 mutation 52 HIV infected 52 Japanese Encephalitis vaccine 52 antiviral prophylaxis 52 solithromycin 52 virologic suppression 52 NS5b 52 CD8 T cell 52 HCV replicon 52 HIV serostatus 52 clade B 52 Human Papilloma Virus HPV 52 Heplisav 52 H#N# viruses 52 immunosuppression 52 Protease Inhibitors 52 NY ESO 52 pyrazinamide 52 pneumococcal serotypes 52 systemic lupus erythematosus SLE 52 nucleoside analogues 52 ABCB1 52 protease inhibitors PIs 52 Intercell vaccine 52 Velcade bortezomib 52 quadrivalent human papillomavirus 52 Arranon 51 S. enterica 51 tenofovir DF 51 poor metabolizers 51 K ras 51 mRCC 51 polioviruses 51 Boceprevir 51 zidovudine AZT 51 interferon IFN 51 HCMV 51 antibody titers 51 nitazoxanide 51 M. bovis 51 cervical cytology 51 ESBLs 51 human papillomavirus HPV 51 mitochondrial toxicity 51 S Typhi 51 BRCA2 gene mutation 51 monoinfected patients 51 Gag Pol 51 invasive fungal infections 51 NNRTI resistant virus 51 immunosuppressive therapies 51 ertapenem 51 LAIV 51 variant allele 51 IgA 51 S aureus 51 virologic responses 51 INTELENCE 51 Adjuvanted 51 infectivity 51 P. falciparum malaria 51 S. aureus colonization 51 Cytomegalovirus 51 QuantiFERON 51 interferon lambda 51 genotypic 51 ELISpot 51 titers 51 invasive aspergillosis 51 HSV1 51 VIR# 51 nontuberculous mycobacteria 51 metastatic neuroendocrine tumors 51 cervical neoplasia 51 trivalent influenza vaccine 51 YERVOY 51 trichomonas 51 Her2/neu 51 KRAS mutations 51 herpes zoster vaccine 51 immunosuppressed 51 tumor antigen 51 Epivir 51 Chlamydia trachomatis infection 51 varicella zoster virus 51 antiviral activity 51 serologically 51 ASCUS 51 induces antibodies 51 rhinovirus infections 51 oral prodrug 51 BCR ABL inhibitors 51 nucleoside analog 51 Mycobacterium tuberculosis TB 51 Inactivated 51 viral hepatitis 51 antigens 51 NRTI 51 syngeneic 51 pathogenic viruses 51 vaccine serotypes 51 CD4 + T lymphocytes 51 sustained virologic response 51 b Hib 51 calcineurin inhibitors 51 clade C 51 mycobacterium tuberculosis 51 Haptoglobin 51 herpes zoster 51 immunodeficiency 51 IgG 51 Cethromycin 51 Salmonella Typhi 51 chronic hepatitis C 51 antibiotic prophylaxis 51 WNV infection 51 GISTs 51 maraviroc 51 nosocomial infection 51 viral load 51 perinatal transmission 51 antifungal therapy 51 presymptomatic 51 nonnucleoside reverse transcriptase inhibitors 51 Zolinza 51 HPV types 51 darunavir 51 antibodies 51 antiviral therapies 51 chemotherapy induced neutropenia 51 PCa 51 BRCA2 mutation 51 FeLV 51 CYP#C# * 51 CCR5 tropic 51 Hepatitis B. 51 antimicrobial prophylaxis 51 Entecavir 51 linezolid resistant 51 effector function 51 carbapenem resistant 51 HepaGam B 51 interferon 51 Thiovir 51 Chronic Hepatitis B 51 HBeAg positive patients 51 efalizumab 51 Pegylated Interferon 51 Sustiva efavirenz 51 invasive candidiasis 51 NRTI backbone 51 Elvitegravir 51 Pneumococcus 51 C. difficile toxins 51 trivalent inactivated influenza 51 gonorrhoeae 51 conjugate vaccines 51 hypereosinophilic syndrome 51 Plasmodium ovale 51 AAV2 51 oral antiviral 51 neutralizing antibody 51 ApoE4 51 Reverset 51 resistant isolates 51 Helicobacter pylori H. pylori 51 protease inhibitor 51 immunocompromised patients 51 ritonavir boosted protease inhibitor 51 MLH1 51 pneumococcal vaccination 51 HNPCC 51 virus 51 heterozygous 51 KIF6 gene 51 intestinal polyps 51 Hepatitis C Virus HCV 51 inhibitor RG# 51 ISENTRESS 51 inactivated vaccine 51 potent antiretroviral therapy 51 Tofacitinib 51 P. vivax malaria 51 congenital CMV infection 51 sJIA 51 serogroups 51 Plasmodium falciparum 51 severe rotavirus gastroenteritis 51 EGFR tyrosine kinase inhibitors 51 Influenza Type 51 acute myelogenous leukemia AML 51 LCMV infection 51 inactivated influenza vaccine 51 wild poliovirus 51 stavudine d4T 51 transgenic rats 51 Meningococcal Meningitis 51 respiratory viruses 50 non adjuvanted vaccine 50 Shigella bacteria 50 macrolides 50 co trimoxazole 50 prostate cancer PCa 50 bendamustine 50 antiretroviral regimens 50 IgA antibodies 50 hereditary hemochromatosis 50 Infected Patients 50 Amplicor 50 CCR5 inhibitor 50 therapeutic regimens 50 Interferon alfa 50 Therapy HAART 50 Genital herpes 50 Adenomas 50 beta thalassemia 50 quadrivalent vaccine 50 epithelial ovarian cancer 50 Viral Load 50 T2DM 50 virologic 50 T. cruzi 50 cagA 50 CD4 lymphocyte count 50 breast carcinoma 50 herpes simplex virus 50 virulence determinants 50 Mycobacterium tuberculosis MTB 50 Vesivirus 50 Adenovirus 50 polysaccharide vaccines 50 cART 50 renal toxicity 50 grade cervical dysplasia 50 Mycobacterium tuberculosis 50 HBV vaccination 50 nucleoside 50 inactivated influenza vaccines 50 imipenem 50 HIV seropositive 50 Hybrid Capture 50 meropenem 50 P aeruginosa 50 superficial bladder cancer 50 refractory gout 50 staphylococci 50 neuraminidase inhibitor 50 adenovirus infections 50 mutated K ras 50 MAGE A3 50 Clusterin 50 Dapagliflozin 50 mAb 50 independent prognostic marker 50 autoantibody 50 rhGH 50 APTIMA R 50 anal HPV 50 Valcyte 50 oseltamivir resistant influenza 50 Pneumocystis carinii pneumonia 50 HbF 50 indinavir 50 heterologous 50 highly pathogenic influenza 50 activating mutation 50 gastrointestinal stromal tumors GIST 50 relapsing remitting MS RRMS 50 TNF α 50 rilpivirine 50 empiric therapy 50 colorectal carcinomas 50 Chronic Hepatitis C 50 erlotinib Tarceva ® 50 ethambutol 50 viral suppression 50 parainfluenza virus 50 ORENCIA ® 50 Extensively drug 50 lymphocytic choriomeningitis virus LCMV 50 antibody 50 Live Attenuated Influenza Vaccine 50 rifampin 50 adefovir dipivoxil 50 GABHS 50 Interferon alpha 50 HSCT 50 mutation 50 NRTIs 50 euthyroid 50 Blinatumomab 50 ORENCIA 50 HbA1C 50 nonvaccine serotypes 50 HLA alleles 50 daptomycin 50 staphylococcal 50 candidemia 50 chronically infected 50 CD4 + CD# 50 Simian Immunodeficiency Virus 50 HCV Genotype 50 P vivax 50 voriconazole 50 serum HBV DNA 50 influenza virus 50 recombinant hepatitis B 50 sputum smear 50 drugs isoniazid 50 HDACi 50 EBV 50 variant alleles 50 tuberculosis TB 50 severe oral mucositis 50 coagulase 50 hepatocellular cancer 50 enfuvirtide 50 HTLV 50 nonvaccine 50 REYATAZ ® 50 decitabine 50 Tyzeka 50 Hemophilia B 50 pneumococcal pneumonia 50 precancers 50 lupus anticoagulant 50 human leukocyte antigen 50 severe hyperbilirubinemia 50 VivaGel ™ 50 TACI mutations 50 Oritavancin 50 pegylated interferons 50 T#I [002] 50 HER2 50 imatinib resistance 50 HCV polymerase inhibitor 50 latent tuberculosis TB 50 nucleoside reverse transcriptase inhibitor 50 multiple myeloma MM 50 micafungin 50 lymphoid organs 50 Klebsiella pneumonia 50 Civacir 50 virus subtype 50 peritoneal carcinomatosis 50 MenB strains 50 pandemic influenza virus 50 Prophylaxis 50 rheumatoid factor 50 zidovudine lamivudine 50 TTR gene 50 histological subtype 50 sustained virological response 50 advanced neoplasia 50 meningococcal bacteria 50 rhinovirus infection 50 quinolones 50 SSc 50 colorectal cancer 50 immunosuppressive regimens 50 bloodborne 50 somatic mutations 50 WT1 50 Saquinavir 50 Nilotinib 50 genital ulcers 50 TB 50 serum antibody 50 pancreatic adenocarcinoma 50 FELV 50 varicella chickenpox 50 postexposure 50 gastric cancer 50 hMPV 50 EGFR antibodies 50 Aliskiren 50 ano genital warts 50 polyclonal 50 peptide antigens 50 HLA B# 50 immunosuppressives 50 H5 viruses 50 S. Typhi 50 genital tract 50 Severe Primary IGFD 50 Ad5 vector 50 transcriptase inhibitors 50 basal cell nevus syndrome 50 Streptococcus pneumoniae 50 naive HCV 50 immune globulins 50 acute rheumatic fever 50 BRCA1 mutations 50 elvitegravir 50 S. aureus isolates 50 Epratuzumab 50 lupus nephritis 50 Cloretazine 50 neutralizing antibody responses 50 urothelial carcinoma 50 microsatellite instability 50 APTIVUS r 50 Maribavir 50 leukemia CLL 50 transcriptase inhibitors NNRTIs 50 PCV1 50 ganciclovir 50 AAT deficiency 50 Virus Infection 50 simian foamy virus 50 HEPLISAV combines 50 ALK inhibitors 50 isoniazid 50 protein tyrosine phosphatase 50 EGFRvIII 50 nasal carriage 50 NAbs 50 Rh positive 50 HBV infections 50 TNFa 50 Cancidas 50 malignant lymphoma 50 lymphomas 50 herpes viruses 50 hepatorenal syndrome 50 tetanus diptheria 50 K RAS 50 elevated ALT 50 PCV7 50 Dengue virus 50 virological response 50 CYP#C# [001] 50 serotype 50 replicase 50 CanAg 50 Decitabine 50 gatifloxacin 50 Poliovirus 50 IL#B 50 HAAH 50 nucleoside naive patients 49 mAbs 49 PREVNAR 49 Progressive Multifocal Leukoencephalopathy 49 Opportunistic infections 49 Paromomycin 49 neonatal tetanus 49 Alferon N 49 highly immunogenic 49 canakinumab 49 orthopoxvirus 49 hematological malignancy 49 monoinfected 49 humanized antibody 49 CERVARIX 49 P. aeruginosa 49 influenza 49 plasma kallikrein 49 falciparum malaria 49 tumor recurrence 49 metastatic disease 49 lipoatrophy 49 cervical carcinoma 49 CaP 49 Pseudomonas aeruginosa infections 49 APOE e4 49 BRAF gene 49 PEG IFN 49 estrogen receptor ER 49 CCR5 antagonists 49 Varicella 49 Therapeutic Vaccine 49 chronic myeloid leukemia CML 49 Haemophilus influenza type 49 Malaria parasite 49 atazanavir sulfate 49 deleterious mutation 49 ADPKD 49 Respiratory Virus 49 seroprotection 49 CCR5 inhibitors 49 CTAP# Capsules 49 transgene expression 49 androgen receptor AR 49 chemokine receptors 49 H5 strains 49 virologically 49 HspE7 49 adenomatous polyps 49 titer 49 Telintra 49 HNSCC 49 H.I.V. 49 Helicobacter pylori 49 artemisinins 49 antibody MAb 49 antiretroviral regimen 49 Omacetaxine 49 TB bacterium 49 promoter methylation 49 Altastaph 49 influenza A/H#N# virus 49 antiretroviral therapy 49 Latent TB 49 parasitemia 49 Viread Emtriva 49 rituximab Rituxan 49 renal allograft 49 non metastatic osteosarcoma 49 MSH2 49 abacavir lamivudine 49 predictive biomarkers 49 PTLD 49 attenuated strain 49 acellular pertussis DTaP 49 discontinued Viread 49 Anaplasmosis 49 oseltamivir resistant 49 Trofile 49 valacyclovir 49 MALT lymphoma 49 SEBIVO 49 acute GVHD 49 dengue haemorrhagic fever DHF 49 antiretroviral naive 49 varicella 49 immunosuppressive agents 49 HBV genotypes 49 etiologic agent 49 breast cancer metastasis 49 fecal occult blood 49 chronic HCV genotype 49 bacterial pneumonias 49 investigational integrase inhibitor 49 tissue transglutaminase 49 log# reduction 49 trivalent vaccine 49 methylated DNA 49 hepatitis C. 49 rubella hepatitis 49 proctitis 49 telaprevir VX 49 Serologic 49 Alferon LDO 49 Escherichia coli Klebsiella pneumoniae 49 Streptococcus pneumonia 49 hepatic fibrosis 49 palivizumab 49 Genital Herpes 49 rifamycins 49 Acute Radiation Syndrome ARS 49 RSV infections 49 antibody mediated 49 HLA DRB1 * 49 precancerous cervical lesions 49 posterior uveitis 49 Fatty Liver Disease 49 pharmacokinetic interactions 49 adjuvanted H#N# 49 monoclonal antibody mAb 49 Plasmodium falciparum malaria 49 antibody titres 49 chronic hepatitis C. 49 varicella infection 49 anti JCV antibodies 49 virus HCV infection 49 Hepatitis B Hepatitis C 49 TransVax 49 atazanavir 49 EGFR 49 PCV7 vaccine 49 Conjugate Vaccine 49 Alinia 49 BRSV 49 BAL# [001] 49 papilloma virus 49 Dengue Virus 49 Dasatinib 49 ImmuKnow 49 orchitis 49 VUR 49 Pharmacokinetics PK 49 Tindamax R 49 neuroblastoma tumors 49 Aptivus ® 49 Traficet EN 49 BRAF V# mutation 49 carcinoembryonic antigen CEA 49 methicillin resistant MRSA 49 H#N# influenza viruses 49 SIMPONI TM 49 HHV 6 49 liver histology 49 HCV viral 49 noncarriers 49 colorectal cancers 49 Streptococcus pneumoniae pneumococcus 49 ALT normalization 49 trimethoprim sulfamethoxazole 49 VEGF inhibitors 49 murine leukemia virus 49 systemic lupus erythematosus 49 microdeletions 49 FluCide 49 cefepime 49 PROSTVAC VF 49 Antiretroviral therapy 49 malaria endemic regions 49 pandemic H#N# virus 49 Multidrug resistant 49 peripheral blood mononuclear 49 lymphocytosis 49 ZOSTAVAX 49 Hib disease 49 abnormal Pap smears 49 intracranial hemorrhage ICH 49 Rimantadine 49 polymerase inhibitors 49 DermaVir Patch 49 LQTS 49 HBsAg positive 49 mutant alleles 49 HAART regimens 49 M#V 49 artemisinin resistance 49 sputum microscopy 49 Irinotecan 49 gastric carcinoma 49 Alemtuzumab 49 CLL cells 49 HAART 49 treatment naive genotype 49 platelet reactivity 49 mycophenolate mofetil MMF 49 Marburg virus infection 49 ChimeriVax JE 49 genotype 1b 49 gonococcal infection 49 serostatus 49 dengue virus 49 genital lesions 49 oncogenic HPV 49 viral loads 49 AZT 3TC 49 HCV SPRINT 49 Cardiotoxicity 49 Anti retroviral therapy 49 Twinrix 49 anti CD3 49 Rh factor 49 CD4 + T 49 sCJD 49 Haemophilus influenza